Teriflunomide Tablet
Product Images NDC 69339-170

11 FDA label images from Natco Pharma Usa Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Teriflunomide (NDC 69339-170). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Natco Pharma Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Teriflunomide Structure)

Structure (Teriflunomide Structure)
Chemical structure of teriflunomide, showing its molecular framework with a trifluoromethyl-substituted aromatic ring, an amide linkage, and a cyano group attached to an unsaturated carbonyl structure.*
FDA Label Image

Teriflunomide-figure-1 (Teriflunomide Figure 1)

Teriflunomide-figure-1 (Teriflunomide Figure 1)
A line graph comparing disability progression sustained over 12 weeks (%) for placebo versus 7 mg and 14 mg teriflunomide tablets over 108 weeks. The graph includes a legend identifying each group and a table of numbers at risk below the x-axis representing weeks. The 14 mg teriflunomide line shows statistically significant differences versus placebo (p < 0.05).*
FDA Label Image

Teriflunomide-figure-2 (Teriflunomide Figure 2)

Teriflunomide-figure-2 (Teriflunomide Figure 2)
A line graph showing disability progression sustained for 12 weeks (%) over time (weeks) comparing placebo, 7 mg teriflunomide tablets, and 14 mg teriflunomide tablets. The vertical axis represents disability progression percentage, and the horizontal axis indicates weeks up to 108. Lines illustrate increasing progression percentages for each group, with 14 mg teriflunomide showing a statistically significant difference compared to placebo (p < 0.05). A table below the graph shows the number of subjects at risk for each group at various time points.*
FDA Label Image

Bottle-label (Teriflunomide Tablets 14mg 30s)

Bottle-label (Teriflunomide Tablets 14mg 30s)
Label for Teriflunomide Tablets 14 mg oral tablets, packaged with 30 tablets. The label includes dosage strength, NDC 69339-170-03, and states Rx only. It carries warnings, storage instructions, and manufacturer information for Natco Pharma USA LLC. The label features the Natco Pharma USA logo and barcode.*
FDA Label Image

Bottle-label (Teriflunomide Tablets 14mg 90s)

Bottle-label (Teriflunomide Tablets 14mg 90s)
Teriflunomide Tablets 14 mg oral tablets packaging label. The label shows a 90-tablet count with directions to dispense a medication guide. Manufactured by Natco Pharma Limited, India, and labeled for Natco Pharma USA LLC. The label includes a barcode, usual dosage instructions, storage conditions, and warnings to keep out of reach of children.*
FDA Label Image

Bottle-label (Teriflunomide Tablets 7mg 30s)

Bottle-label (Teriflunomide Tablets 7mg 30s)
Label for Teriflunomide Tablets 7 mg oral tablets, containing 30 tablets per bottle, labeled Rx only. The label includes storage instructions, manufacturer Natco Pharma Limited India, and labeler Natco Pharma USA LLC, Parsippany, NJ. It also features a barcode, dosage guidance, warnings, and packaging details.*
FDA Label Image

Bottle-label (Teriflunomide Tablets 7mg 90s)

Bottle-label (Teriflunomide Tablets 7mg 90s)
Label for Teriflunomide Tablets 7 mg oral tablets, packaged as 90 tablets. The label includes dosing information stating each tablet contains 7 mg of teriflunomide and usual dosage is one tablet daily. It is labeled Rx only and manufactured by Natco Pharma Limited, India, for Natco Pharma USA LLC. The label also contains storage instructions and a barcode.*
FDA Label Image

14mg-wallet-carton (Teriflunomide Tablets 14mg 30s Wallet Carton)

14mg-wallet-carton (Teriflunomide Tablets 14mg 30s Wallet Carton)
Packaging label for Teriflunomide Tablets, 14 mg per tablet, oral tablet form. The carton indicates a quantity of 30 unit-dose tablets (2x15) and is labeled for prescription use only. Manufactured by Natco Pharma USA LLC, Parsippany, NJ. Includes storage instructions and medication guide dispensing note. The label design includes brand and generic names prominently.*
FDA Label Image

14mg-inner-carton (Teriflunomide Tablets 14mg 30s Inner Carton)

14mg-inner-carton (Teriflunomide Tablets 14mg 30s Inner Carton)
Teriflunomide Tablets 14 mg oral tablet packaging label from Natco Pharma USA LLC. The label features a blister card layout showing 28 tablets arranged in a 4 by 7 grid to represent a 28-day supply. The label includes dosage strength, the labeler information, storage instructions, and a barcode, as well as marking for daily dosing with numbered tablet positions.*
FDA Label Image

7mg-wallet-carton (Teriflunomide Tablets 7mg 30s Wallet Carton)

7mg-wallet-carton (Teriflunomide Tablets 7mg 30s Wallet Carton)
Packaging label for Teriflunomide Tablets 7 mg oral tablets by Natco Pharma USA LLC. The label indicates the product is prescription only with a package count of 30 tablets (2x15 unit-dose tablets). The label includes usage instructions, storage information, and a barcode along with fold and use instructions for the carton.*
FDA Label Image

7mg-inner-label (Teriflunomide Tablets 7mg 30s Inner Carton)

7mg-inner-label (Teriflunomide Tablets 7mg 30s Inner Carton)
Packaging label for Teriflunomide Tablets 7 mg oral tablets, labeled with dosage instructions and a 28-day pill organizer layout. The label shows the Natco Pharma USA LLC name as the labeler and manufacturer, with storage instructions and Rx only designation. The label includes daily markings for medication adherence.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.